Variation in epitopes of the B subunit of cholera toxin (CT-B) produced by strains of El Tor and classical biotype Vibrio cholerae 0 1 was examined using monoclonal antibodies prepared to V. cholerae 569B CT. CT-B epitopes were markedly conserved for V. cholerae classical biotypes. In contrast, epitope variation was observed for El Tor biotypes, which produced both a classicallike CT-B and a unique CT-B lacking at least one epitope common to 569B CT-B. The missing epitope was located outside the GM, ganglioside-binding site. From results of the study reported here, genetic divergence is exhibited in the El Tor biotype CT-B versus classical CT-B. Furthermore, at least five unique epitopes of V. cholerae 569B CT-B can be defined.
I N T R O D U C T I O N
Vibrio cholerae produces a heat-labile enterotoxin, cholera toxin (CT), which contributes to cholera, the clinical diarrhoea1 disease. CT is composed of two subunits (Lonnroth & Holmgren, 1973) . The B subunit (CT-B) is a noncovalent aggregate of identical polypeptides (typically five) that binds the holotoxin to cell GM1 ganglioside receptors. The A subunit (CT-A) is an ADPribosyltransferase, stimulating CAMP production by the membrane-associated adenylate cyclase enzyme complex.
The nucleic acid and amino acid sequences of various CTs comprising the cholera toxin family of proteins have been reported (Dallas & Falkow, 1980; Pearson & Mekalanos, 1982) . However, sequence analyses alone have not been sufficient to define the three-dimensional structure of CT. In recent years, monoclonal antibodies (mAbs) have been utilized to probe CT-A and CT-B, defining several unique epitopes (Remmers et al., 1982; Robb et al., 1982; Holmes & Twiddy, 1983; Lindholm et al., 1983; Imagawa et al., 1986; Ludwig et al., 1986; Tamplin et al., 1988) . Further studies have defined epitopes by testing whether anti-CT and anti-LT mAbs cross-react with Escherichia coli heat-labile enterotoxins (LT) and CTs (Robb et al., 1982; Holmes & Twiddy, 1983; Lindholm et al., 1983; Belisle et a/., 1984; Finkelstein et al., 1986 Finkelstein et al., , 1987 Imagawa et al., 1986; Tamplin et al., 1988) . The results indicate that CT and LT have both common and unique epitopes, supporting the hypothesis that CT and LT are phylogenetically related (Finkelstein et al., 1986; Yamamoto et al., 1987) . Additional epitopes have also been defined in the GM1 ganglioside-binding site of CT and LT (Ludwig et al., 1986; Finkelstein et al., 1987; Tamplin et al., 1988) . Using different techniques, Ludwig et al. (1986) Previous descriptions of the diversity of CT-B epitopes have referred to a limited number of prototype toxins (e.g. V. cholerae 569B CT and E. coli LTh and LTp), and to chimeric, not natural toxins (Finkelstein et al., 1987) . In addition, little is known of the extent and frequency of epitope variations within and between biotypes of V. cholerae 01. In the study reported here, epitopes of CT-B prepared from strains of El Tor and classical biotypes of V. cholerae 0 1 were compared. We report greater variation among epitopes of El Tor V. cholerae 0 1 CT-B than classical V. cholerae 0 1 CT-B.
M E T H O D S
Bacteria. The biotype, serotype and source of the V. cholerae 0 1 strains are shown in Table 1 . Bacteria were selected randomly from a collection of toxigenic isolates maintained at the University of Maryland, College Park. Biotype was determined using methods described by Furniss (1979) . All bacterial isolates were stored under liquid nitrogen until assay. V. cholerae CVDlOl and E. coli CVD2 were generously provided by J. B. Kaper and J. Michalski of the Center for Vaccine Develophent, University of Maryland, Baltimore, Maryland, USA.
Bacterial culture. Cholera toxin prepared from cultures of the 10 classical and 10 El Tor strains was subjected to the tests described below. Several colonies of bacteria from 18 h growth on tryptic soy agar (TSA) (Difco) were transferred to 125 ml flasks containing 50 ml CAYEG broth, pH 7.4 (Sack et ul., 1980). Flasks were shaken at 100 r.p.m. for 18 h at 37 "C.
Preparation ofpurified toxin. Toxin was purified using a modification of the method of Yamamoto et al. (1983) . A 0.1 ml volume of a mid-exponential-phase culture was added to a Fernbach flask containing 500 ml CAYEG and the culture shaken at 100 r.p.m. for 24 h at 37 "C. A total of 2 1 of culture was pooled and centrifuged at 3000g for 15 min and the culture supernate was removed and adjusted to pH 5-0 with concentrated HC1. Next, aluminium hydroxide was added slowly to the supernate to a final concentration of 0.1 %, then gently mixed at 7 "C for 18 h.
The resulting precipitate was collected by centrifugation at 9000 g and 4 "C, and washed three times with 100 ml 0.01 M-ammonium formate, pH 5.0. Toxin was eluted from the precipitate at 4 "C with four washes of elution buffer (50 mM-Tris/HCl, 1.0 mM-EDTA, 3.0 mM-NaN, and 0-2 M-NaCl: TEAN). Pooled washes were concentrated by ultrafiltration at 4 "C with a stirred-cell (Amicon) fitted with a 10000 M , exclusion membrane (YM 10). This preparation of concentrated toxin was used in subsequent ELISAs. Purified V. cholerae 569B CT was purchased from Sigma and used as reference toxin.
Epitope analysis by CT ELISA. The ELISA method used to characterize the CT epitopes has been reported (Tamplin & Colwell, 1986) . Polyvinyl chloride microtitre plates were coated with CT affinity-purified rabbit anti-CT serum in 0.1 M-carbonate buffer, pH 9.6. The wells were washed with 0.05% Tween 20/0.15 M-NaCl, then blocked with 1 % (w/v) bovine serum albumin (Sigma)/phosphate buffered saline (5-0 mM-Na2HP04, 1.5 mM-KH2P04, 0.13 M-NaCl, pH 7.4). A sample of toxin was added to the wells and next reacted with optimal dilutions of hybridoma supernate. Bound mouse IgG was detected with horseradish-peroxidase-conjugated goat anti-mouse IgG. Uninoculated broth and culture supernate of non-CT-producing I/. cholerae strains were used as negative controls.
Methods used to treat CT with GM, ganglioside and to measure the effect on mAb binding have been described elsewhere (Tamplin et al., 1988) .
RESULTS AND DISCUSSION
CT-B produced by classical biotype V. cholerae 0 1 reacted with all mAbs produced to 569B CT (Table 2, Fig. 1 ). The high degree of conservation among classical strains was in marked contrast to results obtained for V. cholerae El Tor strains, which showed at least two, and potentially three classes of mAb reaction patterns (Table 2, Fig. 1) . Four of the ten El Tor strains (34, E506, SGN7700 and SGN7727) showed identical reaction patterns when compared with classical type 569B CT-B. In contrast, six strains produced CT-B that did not react with mAb 45 (A,2o < 0.100). Within this group, four strains (E9120, 192, 102 and 30167) produced CT-B that reacted weakly with mAb 65. Possibly the tertiary structure of CT-B amino acids required for complete reaction with mAb 65 was not present when mAb 45 epitope was absent, resulting in only partial binding. CT-B produced by strains N16961 and CVD 2 did not react with mAb 65.
Variation in El Tor CT-B epitopes was significant, as evidenced by the ratio of reaction with mAb 45 to that with mAb 53 (not shown). Specifically, the ratio was greater than 0.970 for classical type CT-B, and less than 0.260 for variant El Tor CT-B. Similarly, the reaction ratio of mAb 65 to 3E7 was greater than 1-000 for classical CT-B, and less than 0.550 for variant El Tor CT-B. Previously, we reported at least four individual epitopes on CT-B of V. cholerae strain 569B (Tamplin et al., 1988) . The mAbs used in those studies were characterized using CT-B and LT in cross-reaction and ganglioside blocking experiments. Three of four epitopes were concluded to be located in or near the G M I ganglioside-binding site. The present study defines a fifth epitope on 569B CT-B which is not present on V . cholerae 102 CT-B, or E. coli LTp and LTh. Since the present experiments examine CT-B relative to 569B CT-B, it is not known if epitypes of El Tor CT-B lack amino acid structure(s) that form 569B-like epitopes or have a unique epitope at the site. Such information will be possible by developing mAbs to variant El Tor CT-B and testing these mAbs against other CT-like enterotoxins.
These results also demonstrate that El Tor CT-B epitopes can vary outside the G M , ganglioside-binding site, supporting the hypothesis that amino acid diversity occurs also in structures of CT-B that are not involved in receptor binding. Furthermore, the observed variations in reactions of mAb 65 may yet define a sixth epitope.
Because of the unique CT-B epitopes described in this and previous studies, it is suggested that in the development of synthetic or natural vaccines to cholera consideration should be given to epitope variation in the CT-B molecule. An appropriate vaccine may need to reflect crossreacting epitopes shared by classical and El Tor V. cholerae strains, as well as by E. coli and related bacterial pathogens producing a CT-like molecule. This may afford broad protection against various bacterial enteropathogenic diseases. Finally, defining the epitopes of CT-A and CT-B allows characterization of enterotoxins which may prove useful in the epidemiology of cholera, e.g. detection, geographic location of variants, and determination of relationships of variants to severity of disease and/or epidemic.
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